OpenVSafe by OpenVAERS
Search V-safe

ECU-10869-99416

2 vaccinations 10 coded responses 21 check-ins 10 free-text entries 4 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
290 / SC
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-30
    Registered in v-safe
  3. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2020-12-30
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Headache, Pre-existing disease — Feeling: Good · Headache
    Free text: I have a PMH migraines so I get headaches often all the time. I do kot think the headache today is related.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-12
    Survey response — day 14, dose 1
    MedDRA: Hand dermatitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Moderate eczema to bilateral hands beginning on day 7, no prior history of eczema.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-12
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-18
    Survey response — day 0, dose 2
    MedDRA: Eczema — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Eczema still present from first dose, reappearwd 15 minutes before my appointment for the second dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-18
    Report sent to call center — day 0, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eczema, Immediate post-injection reaction — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Still present since 1 week after first dose, new onset eczema to bilateral hands. Never had eczema prior to this
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eczema — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Still having new onset eczema since first dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Good · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Nasal congestion, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  18. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-01-25
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-02-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-08
    Survey response — day 21, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-15
    Survey response — day 28, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Good
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-01
    Survey response — day 42, dose 2
    MedDRA: Rash — Feeling: Good · Be unable to do your normal daily activities
    Free text: Rash
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-04-19
    Survey response — 3 months, dose 2
    MedDRA: Skin ulcer, Tattoo associated skin reaction — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I have never reacted negatively when receiving tattoos before. The two tattoos I have gotten since the vaccine have ulcerated, become open wounds, and rejected the ink.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-19
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-06-08
  28. 2021-07-19
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  29. 2022-01-19
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-18Pfizer-BioNTech

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-02

Systemic reaction (other): I have a PMH migraines so I get headaches often all the time. I do kot think the headache today is related.

Release 1 — day 14, dose 1

2021-01-12

Symptoms: Moderate eczema to bilateral hands beginning on day 7, no prior history of eczema.

Release 2 — day 0, dose 2

2021-01-18

Systemic reaction (other): Eczema still present from first dose, reappearwd 15 minutes before my appointment for the second dose

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Still present since 1 week after first dose, new onset eczema to bilateral hands. Never had eczema prior to this

2021-01-21

Systemic reaction (other): Still having new onset eczema since first dose

2021-01-22

Systemic reaction (other): Nasal congestion, sore throat

Release 3 — day 21, dose 2

2021-02-08

Symptoms: Runny nose

Release 4 — day 28, dose 2

2021-02-15

Symptoms: Sore throat

Release 4 — day 42, dose 2

2021-03-01

Symptoms: Rash

Release 7 — 3 months, dose 2

2021-04-19

Symptoms: I have never reacted negatively when receiving tattoos before. The two tattoos I have gotten since the vaccine have ulcerated, become open wounds, and rejected the ink.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHand dermatitis ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SDSkin ulcer ✓ ✓ ✓
SDTattoo associated skin reaction ✓ ✓ ✓
SROEczema ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROImmediate post-injection reaction ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release